Peppermint (Mentha × piperita)

Table of Contents

1. Origins of a Hybrid Herb
2. Active Compounds
3. Irritable Bowel Syndrome
4. Functional Dyspepsia
5. Tension Headache
6. Respiratory Use
7. Antimicrobial Activity
8. Forms and Preparations
9. Dosage Used in Studies and Monographs
10. Cautions and Contraindications
11. Featured Videos

Origins of a Hybrid Herb

Peppermint is a sterile hybrid of watermint (Mentha aquatica) and spearmint (Mentha spicata) that was first documented in England in the 1690s and named Mentha piperita by Linnaeus in 1753 — making it one of the younger herbs in the Western tradition, even though the genus reaches back to Greek myth. The plant carries the ancient digestive reputation of mint generally, and its cooling compound, menthol, was first isolated in 1771. — the fuller story is told in the dedicated History & Traditional Use article.

Back to Table of Contents

Active Compounds

The principal active component is menthol, a cyclic terpene alcohol that constitutes 35-55% of peppermint essential oil. Menthol activates the TRPM8 cold-sensing receptor on sensory neurons, producing the characteristic cooling sensation, and has multiple additional pharmacological effects:

• Smooth muscle relaxation — inhibits calcium channels in intestinal smooth muscle, producing antispasmodic effects
• Local anesthetic activity — desensitizes pain receptors at higher concentrations
• Antimicrobial activity — against many bacteria, fungi, and viruses
• Anti-inflammatory effects — reduces inflammatory cytokine production

Other significant constituents include menthone, menthyl acetate, 1,8-cineole, limonene, and pulegone. The full essential oil profile produces synergistic effects beyond what isolated menthol can achieve.

Back to Table of Contents

Irritable Bowel Syndrome

The strongest clinical evidence for peppermint is in irritable bowel syndrome. Multiple randomized controlled trials and meta-analyses have shown that enteric-coated peppermint oil capsules (typically 0.2 mL of oil per capsule, taken twice or three times daily) produce significant improvements in:

• Abdominal pain and discomfort
• Bloating and abdominal distension
• Stool urgency and frequency
• Overall symptom severity scores

The American College of Gastroenterology and the British Society of Gastroenterology both endorse peppermint oil as a first-line therapy for global irritable bowel syndrome (IBS) symptoms. The number needed to treat (NNT) for clinically meaningful improvement is approximately 3 — comparable to or better than many pharmaceutical irritable bowel syndrome therapies.

Enteric coating is essential. Uncoated peppermint oil is absorbed in the upper gastrointestinal (GI) tract and may cause heartburn or burning belches; the enteric coating ensures the oil is released in the small intestine and colon where it is needed.

Back to Table of Contents

Functional Dyspepsia

Peppermint oil, often combined with caraway oil, has been studied for functional dyspepsia (chronic indigestion without identifiable structural disease) with positive results. A standardized multi-herb combination product containing peppermint is one of the most-studied botanical treatments for functional gastrointestinal disorders in Europe.

Peppermint relaxes the lower esophageal sphincter and the pyloric sphincter, which can either help or harm depending on the underlying problem. In dyspepsia from delayed gastric emptying, peppermint can speed transit. In gastroesophageal reflux, it can worsen symptoms by relaxing the LES — so the research raises a concern about peppermint in gastroesophageal reflux disease (GERD).

Back to Table of Contents

Tension Headache

Topical peppermint oil applied to the forehead and temples has been shown in controlled trials to reduce tension headache severity, with effects comparable to acetaminophen at 30 minutes post-application. The mechanism likely involves cold-receptor activation, mild local muscle relaxation, and a counterirritant effect.

The controlled trial (Göbel 1996) and the European Union herbal monograph on peppermint oil (European Medicines Agency, EMA/HMPC/522410/2013) both use a 10% solution of peppermint oil in ethanol, spread across the forehead and temples. In that trial the solution reduced headache intensity within 15 minutes, with no significant difference from 1,000 mg of acetaminophen. The monograph gives one application, repeatable twice at 15-minute intervals, once a day, and does not recommend this use under 18 years of age. It also notes that touching the eyes with unwashed hands after applying the oil can cause irritation. Undiluted peppermint oil on the skin can cause irritation.

Back to Table of Contents

Respiratory Use

Inhaled peppermint vapor has classical use for upper respiratory congestion. Menthol activates cold-sensing receptors in the nasal mucosa, producing a sensation of clearer breathing even when objective measures of airflow do not change significantly. Peppermint is a common ingredient in cough drops, chest rubs (combined with eucalyptus and camphor), and steam inhalation preparations.

Caution: in infants and very young children, menthol-containing products have been associated with respiratory problems and rare cases of laryngospasm; the EU monograph lists children under 2 years as a contraindication.

Back to Table of Contents

Antimicrobial Activity

Peppermint oil has documented activity against a broad spectrum of bacteria, fungi, and protozoa in laboratory studies. Clinically relevant applications include:

• Topical use for fungal skin infections (athlete's foot, ringworm) in dilute form
• Oral hygiene: peppermint is a common ingredient in toothpastes and mouthwashes for breath freshening and mild antibacterial activity
• Some integrative protocols include enteric-coated peppermint oil as a component of broader botanical antimicrobial regimens for small intestinal bacterial overgrowth (SIBO) and intestinal dysbiosis

Back to Table of Contents

Forms and Preparations

• Enteric-coated peppermint oil capsules — the form used in irritable bowel syndrome trials; typically 0.2 mL of oil per capsule
• Peppermint tea — 1-2 teaspoons of dried leaf in hot water for 10 minutes; gentle digestive support and mild relaxant
• Peppermint essential oil (undiluted) — intended only for inhalation or for dilution; undiluted it can irritate the skin, and swallowed without enteric coating it can cause heartburn (see above)
• Topical preparations — 10% peppermint oil in ethanol, the strength used in the headache trial and the EU monograph
• Tinctures — 1:5 alcohol extracts; less commonly used clinically
• Fresh leaves — in salads, beverages, garnishes

Back to Table of Contents

Dosage Used in Studies and Monographs

• Enteric-coated capsules for irritable bowel syndrome — 0.2 mL of peppermint oil per capsule, two or three times daily, 30-60 minutes before meals. The EU monograph gives 0.2–0.4 mL per dose, 0.6–1.2 mL a day, for adolescents and adults, and 0.2 mL three times a day for children aged 8 to 11; it does not recommend the capsules under 8 years, and the capsules are swallowed whole, not broken or chewed, because a broken capsule releases the oil early and can irritate the mouth and gullet
• Peppermint tea — 1-3 cups daily for digestive support
• Topical headache use — 10% peppermint oil in ethanol on the forehead and temples; the EU monograph gives one application, repeatable twice at 15-minute intervals, once a day, and does not recommend this use under 18 years
• Inhalation — a few drops of essential oil in a bowl of hot water, the steam breathed in under a towel; the EU monograph gives 0.08–0.16 mL of oil up to three times a day for adolescents and adults
• Duration — the European Medicines Agency's summary for peppermint-leaf medicines gives use in adults and children over 4 years, with symptoms that worsen or last more than 2 weeks as the point for a medical check. For the enteric-coated capsules, the EU monograph gives use until symptoms resolve, usually within one or two weeks, and, when symptoms persist, no longer than 3 months per course; safe for indefinite daily use of tea; capsule courses for irritable bowel syndrome typically run 4-12 weeks with reassessment

Back to Table of Contents

Cautions and Contraindications

• Gastroesophageal reflux disease — relaxes the lower esophageal sphincter and can worsen reflux; the EU monograph notes that people who already have heartburn or a hiatal hernia sometimes get worse on peppermint oil, and that treatment is stopped in them
• Hiatal hernia — same mechanism, covered by the same monograph warning
• Gallstones, liver and bile disease — peppermint can increase bile flow and may bring on biliary colic in people with gallstones. For the oral oil capsules, the EU monograph lists liver disease, cholangitis (inflamed bile ducts), achlorhydria (no stomach acid), gallstones and any other bile disorder as contraindications
• Infants and young children — the EU monograph lists children under 2 years as a contraindication, because menthol can trigger reflex apnoea (breathing stops) and laryngospasm, and also children with a history of seizures, with or without fever. It does not recommend inhaled, oral or skin use of the oil from 2 to 11 years, or the irritable bowel syndrome capsules under 8 years. Warnings on menthol products concern especially the face and chest of infants
• Pregnancy and breastfeeding — moderate use as food is not what the warning covers. For peppermint oil, including the ordinary irritable bowel syndrome capsule dose, the EU monograph states that safety in pregnancy and breastfeeding has not been established and that use is not recommended
• Allergic skin reaction — topical peppermint can cause contact dermatitis in sensitive individuals; a small skin patch test shows a reaction before wider use
• Drug interactions — mild cytochrome P450 3A4 (CYP3A4) inhibition; relevant when combined with drugs heavily metabolized by this enzyme (cyclosporine, certain statins, calcium channel blockers)

Back to Table of Contents

Key Research Papers

The following PubMed search links provide curated entry points into the published clinical and mechanistic literature on Peppermint (Mentha × piperita). Each link opens directly in PubMed at the National Library of Medicine.

1. Enteric-coated peppermint oil for IBS — PubMed: peppermint oil IBS enteric
2. Peppermint oil for tension headache — PubMed: peppermint oil headache
3. Peppermint and gastric emptying / dyspepsia — PubMed: peppermint dyspepsia
4. Menthol mechanism TRPM8 cooling receptor — PubMed: menthol TRPM8
5. Peppermint antimicrobial activity — PubMed: peppermint antimicrobial
6. Peppermint for endoscopy and antispasmodic use — PubMed: peppermint endoscopy antispasmodic
7. Peppermint safety and reflux — PubMed: peppermint reflux safety

External Authoritative Resources

1. NCCIH — Herbs at a Glance
2. MedlinePlus — Herbs and Supplements
3. PubMed — All research on Mentha × piperita

Back to Table of Contents

Connections

• All Herbs
• Peppermint Benefits Deep Dive
• Irritable Bowel Syndrome
• Ginger
• Lemon Balm
• Fennel
• Migraine
• Chamomile
• Headache
• Reflux and Heartburn
• Bloating
• Small Intestinal Bacterial Overgrowth
• Oregano
• Turmeric
• Abdominal Pain
• Eucalyptus
• Gut Healing
• Herbal Antimicrobials
• Low FODMAP Diet
• Sinusitis
• Mullein
• Conditions on this site that reference this page: Irritable Bowel Syndrome Medications Guide · Peppermint, Probiotics & Herbals for Irritable Bowel Syndrome · Chronic Diarrhea · ENT (Ear, Nose & Throat)
• Caraway

Back to Table of Contents

×

Featured Videos